151 related articles for article (PubMed ID: 34361118)
1. Mechanistic and Predictive QSAR Analysis of Diverse Molecules to Capture Salient and Hidden Pharmacophores for Anti-Thrombotic Activity.
Zaki MEA; Al-Hussain SA; Masand VH; Sabnani MK; Samad A
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361118
[TBL] [Abstract][Full Text] [Related]
2. Exploring the Prominent and Concealed Inhibitory Features for Cytoplasmic Isoforms of Hsp90 Using QSAR Analysis.
Zaki MEA; Al-Hussain SA; Bukhari SNA; Masand VH; Rathore MM; Thakur SD; Patil VM
Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337101
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic Analysis of Chemically Diverse Bromodomain-4 Inhibitors Using Balanced QSAR Analysis and Supported by X-ray Resolved Crystal Structures.
Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Masand VH; Samad A; Jawarkar RD
Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745664
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase B.
Masand VH; Al-Hussain SA; Rathore MM; Thakur SD; Akasapu S; Samad A; Al-Mutairi AA; Zaki MEA
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498857
[TBL] [Abstract][Full Text] [Related]
5. QSAR and Pharmacophore Modeling of Nitrogen Heterocycles as Potent Human
Zaki MEA; Al-Hussain SA; Masand VH; Akasapu S; Lewaa I
Molecules; 2021 Mar; 26(7):. PubMed ID: 33805223
[No Abstract] [Full Text] [Related]
6. Perceiving the Concealed and Unreported Pharmacophoric Features of the 5-Hydroxytryptamine Receptor Using Balanced QSAR Analysis.
Bukhari SNA; Elsherif MA; Junaid K; Ejaz H; Alam P; Samad A; Jawarkar RD; Masand VH
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890133
[TBL] [Abstract][Full Text] [Related]
7. Structure features of peptide-type SARS-CoV main protease inhibitors: Quantitative structure activity relationship study.
Masand VH; Akasapu S; Gandhi A; Rastija V; Patil MK
Chemometr Intell Lab Syst; 2020 Nov; 206():104172. PubMed ID: 33518858
[TBL] [Abstract][Full Text] [Related]
8. QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA.
Jawarkar RD; Bakal RL; Mukherjee N; Ghosh A; Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Samad A; Gandhi A; Masand VH
Molecules; 2022 Jul; 27(15):. PubMed ID: 35897936
[TBL] [Abstract][Full Text] [Related]
9. QSAR studies of HIV-1 integrase inhibition.
Yuan H; Parrill AL
Bioorg Med Chem; 2002 Dec; 10(12):4169-83. PubMed ID: 12413870
[TBL] [Abstract][Full Text] [Related]
10. A class of novel N-(1-methyl-β-carboline-3-carbonyl)-N'-(aminoacid-acyl)-hydrazines: aromatization leaded design, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysis.
Li C; Zhang X; Zhao M; Wang Y; Wu J; Liu J; Zheng M; Peng S
Eur J Med Chem; 2011 Nov; 46(11):5598-608. PubMed ID: 21983333
[TBL] [Abstract][Full Text] [Related]
11. A new class of anti-thrombosis hexahydropyrazino-[1',2':1,6]pyrido-[3,4-b]-indole-1,4-dions: design, synthesis, logK determination, and QSAR analysis.
Liu J; Wu G; Cui G; Wang WX; Zhao M; Wang C; Zhang Z; Peng S
Bioorg Med Chem; 2007 Sep; 15(17):5672-93. PubMed ID: 17590343
[TBL] [Abstract][Full Text] [Related]
12. Discovery of FIXa inhibitors by combination of pharmacophore modeling, molecular docking, and 3D-QSAR modeling.
Li P; Peng J; Zhou Y; Li Y; Liu X; Wang L; Zuo Z
J Recept Signal Transduct Res; 2018 Jun; 38(3):213-224. PubMed ID: 29724133
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
14. Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools.
Roy K; Mandal AS
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):205-23. PubMed ID: 18608745
[TBL] [Abstract][Full Text] [Related]
15. A QSAR for the prediction of rate constants for the reaction of VOCs with nitrate radicals.
Schindler M
Chemosphere; 2016 Jul; 154():23-33. PubMed ID: 27037771
[TBL] [Abstract][Full Text] [Related]
16. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
Aher RB; Roy K
Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
[TBL] [Abstract][Full Text] [Related]
17. Extending the identification of structural features responsible for anti-SARS-CoV activity of peptide-type compounds using QSAR modelling.
Masand VH; Rastija V; Patil MK; Gandhi A; Chapolikar A
SAR QSAR Environ Res; 2020 Sep; 31(9):643-654. PubMed ID: 32847369
[TBL] [Abstract][Full Text] [Related]
18. [Three dimensional quantitative structure-activity relationship of heterocyclic-compounds with di-tert-bultylphenyl inhibitors].
Bai AP; Guo ZR; Chu FM
Yao Xue Xue Bao; 2001 May; 36(5):347-50. PubMed ID: 12584856
[TBL] [Abstract][Full Text] [Related]
19. QSAR of heterocyclic antifungal agents by flip regression.
Deeb O; Clare BW
J Comput Aided Mol Des; 2008 Dec; 22(12):885-95. PubMed ID: 18574697
[TBL] [Abstract][Full Text] [Related]
20. Novel semi-automated methodology for developing highly predictive QSAR models: application for development of QSAR models for insect repellent amides.
Bhonsle JB; Bhattacharjee AK; Gupta RK
J Mol Model; 2007 Jan; 13(1):179-208. PubMed ID: 17048015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
